ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SPOH announcements S&p Con Staples Stocks Above 100-day Average announcements and dividends declared INDICES

S&p Con Staples Stocks Above 100-day Average Complete list of announcements declared & dividend announcements by S&p Con Staples Stocks Above 100-day Average SPOH

S&p Con Staples Stocks Above 100-day Average SPOH listed on INDICES and deals in

Announcements and dividends declared by S&p Con Staples Stocks Above 100-day Average SPOH

Closing Auction Session needs market makers as price swings persist
India’s new 20-minute Closing Auction Session (CAS) absorbed a record .2 billion in MSCI-linked trades on Monday, but sharp price swings persisted despite the surge in volumes. Around 60 stocks hit their 3% price limits, highlighting concerns over thin l
Announcement as on 01 September 2026

UBL sees positive demand momentum in Q2, invests ?110 cr in Maha brewery
United Breweries Ltd (UBL) continues to see positive demand momentum in the first two months of the ongoing second quarter, driven by growth in premium brands, according to its Managing Director and CEO, Vivek Gupta. UBL has maintained its FY27 outlook of
Announcement as on 01 September 2026

India’s passenger vehicle sales jump 35% to 4.5 lakh in August as Maruti, M&M drive growth
Passenger vehicle sales in India soared by 35 percent in August, reflecting a thriving automotive market. Leading manufacturers such as Maruti Suzuki, Tata Motors, and Mahindra & Mahindra reported exceptional growth, while Hyundai and Kia celebrated re
Announcement as on 01 September 2026

RBI intervention, dollar flows push Indian rupee to two-month peak
The Indian rupee surged to a two-month peak against the U.S. dollar, buoyed by decisive central bank interventions and dollars flowing in from foreign banks. Positive domestic growth indicators bolstered confidence in the rupee. However, rising global bond
Announcement as on 01 September 2026

Zydus’ Saroglitazar meets primary goal in global Phase II(b) MASH trial
Zydus Lifesciences said its drug Saroglitazar Magnesium met the primary goal of a global Phase II(b) trial for MASH, a serious liver disease linked to metabolic disorders.
Announcement as on 31 August 2026

Announcements by S&p Con Staples Stocks Above 100-day Average first page | Next page | Prev page |

SPOH S&p Con Staples Stocks Above 100-day Average current price & indicator signals

Moving Averages for S&p Con Staples Stocks Above 100-day Average

  • 5Day Average: 61.76
  • 12Day Average: 67.89
  • 20Day Average: 68.38
  • 50Day Average: 64.1
  • 100Day Average: 53.6
  • 150Day Average: 57.83
  • 200Day Average: 54.22

SPOH Indicators & signals

Indicator MACD (12,26,9)

65.55, 66.32, 0.93
Indicator MACD is in negative zone

Indicator ADX (14)

20.7, 20, 30.44
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SPOH S&p Con Staples Stocks Above 100-day Average are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Thu Sep 2026 61.76 55.88 to 64.70 0% 0 times
02 Wed Sep 2026 61.76 58.82 to 64.70 0% 0 times
01 Tue Sep 2026 61.76 61.76 to 67.64 5% 0 times
31 Mon Aug 2026 58.82 55.88 to 61.76 -9.09% 0 times
28 Fri Aug 2026 64.70 61.76 to 64.70 0% 0 times
27 Thu Aug 2026 64.70 61.76 to 64.70 -8.33% 0 times
26 Wed Aug 2026 70.58 70.58 to 73.52 -4% 0 times
25 Tue Aug 2026 73.52 70.58 to 73.52 -3.86% 0 times
24 Mon Aug 2026 76.47 70.58 to 76.47 4.01% 0 times
21 Fri Aug 2026 73.52 73.52 to 73.52 0% 0 times
20 Thu Aug 2026 73.52 73.52 to 73.52 0% 0 times
19 Wed Aug 2026 73.52 73.52 to 73.52 8.69% 0 times

Videos related to: SPOH announcements S&p Con Staples Stocks Above 100-day Average announcements and dividends declared INDICES

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

SPOH announcements S&p Con Staples Stocks Above 100-day Average announcements and dividends declared INDICES

 

Back to top